Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

Article

Abstract: Background: The combination of 2.5 mg rivaroxaban twice daily and 100 mg aspirin once daily compared

Palabras claves:

aspirin, Coronary artery disease, Mortality , Peripheral artery disease, rivaroxaban

Autores:

Anand S.S., Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Connolly S.J., Dagenais G.R., Eikelboom J.W., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Maggioni A.P., Muehlhofer E., Sharma M., Shestakovska O., Yusuf S.

Fuentes:

google

scopus